Multiple outcomes associated with the use of metformin and sulphonylureas in type 2 diabetes: a population-based cohort study in Italy.

PubWeight™: 0.84‹?›

🔗 View Article (PMID 21088829)

Published in Eur J Clin Pharmacol on November 19, 2010

Authors

Giovanni Corrao1, Silvana Antonietta Romio, Antonella Zambon, Luca Merlino, Emanuele Bosi, Marina Scavini

Author Affiliations

1: Unit of Biostatistics and Epidemiology, Department of Statistics, University of Milano-Bicocca, Via Bicocca degli Arcimboldi, 8, Edificio U7, 20126, Milan, Italy. giovanni.corrao@unimib.it

Articles cited by this

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (1998) 95.79

Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol (1992) 60.45

10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med (2008) 35.49

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ (2000) 35.06

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (1998) 34.34

Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care (1998) 24.53

Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care (2008) 21.05

Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract (1995) 12.51

Tutorial in biostatistics: competing risks and multi-state models. Stat Med (2007) 10.61

The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. Diabetes Care (1999) 9.16

Systematic review: comparative effectiveness and safety of oral medications for type 2 diabetes mellitus. Ann Intern Med (2007) 6.09

A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. II. Mortality results. Diabetes (1970) 4.57

Risk of mortality and adverse cardiovascular outcomes in type 2 diabetes: a comparison of patients treated with sulfonylureas and metformin. Diabetologia (2006) 3.94

Decreased mortality associated with the use of metformin compared with sulfonylurea monotherapy in type 2 diabetes. Diabetes Care (2002) 3.12

Sulfonylurea drugs increase early mortality in patients with diabetes mellitus after direct angioplasty for acute myocardial infarction. J Am Coll Cardiol (1999) 2.87

Long-term prognosis of diabetic patients with myocardial infarction: relation to antidiabetic treatment regimen. The TRACE Study Group. Eur Heart J (2000) 2.86

Multi-state models for event history analysis. Stat Methods Med Res (2002) 2.80

Impact of dosage frequency on patient compliance. Diabetes Care (1997) 2.43

Seminars in Medicine of the Beth Israel Hospital, Boston. Non-insulin-dependent diabetes mellitus - a genetically programmed failure of the beta cell to compensate for insulin resistance. N Engl J Med (1996) 2.42

Risk of cardiovascular disease and all cause mortality among patients with type 2 diabetes prescribed oral antidiabetes drugs: retrospective cohort study using UK general practice research database. BMJ (2009) 2.42

United Kingdom Prospective Diabetes Study 17: a 9-year update of a randomized, controlled trial on the effect of improved metabolic control on complications in non-insulin-dependent diabetes mellitus. Ann Intern Med (1996) 2.41

Estimated benefits of glycemic control in microvascular complications in type 2 diabetes. Ann Intern Med (1997) 2.22

Inside guidelines: comparative analysis of recommendations and evidence in diabetes guidelines from 13 countries. Diabetes Care (2002) 2.21

Coronary care for myocardial infarction in diabetics. Lancet (1974) 2.12

Dose-response relation between sulfonylurea drugs and mortality in type 2 diabetes mellitus: a population-based cohort study. CMAJ (2006) 1.80

Complications in young adults with early-onset type 2 diabetes: losing the relative protection of youth. Diabetes Care (2003) 1.79

Antihyperglycemic treatment in diabetics with coronary disease: increased metformin-associated mortality over a 5-year follow-up. Cardiology (1999) 1.52

Utilization of oral hypoglycemic agents in a drug-insured U.S. population. Diabetes Care (2001) 1.45

The optimal mode of coronary revascularization for diabetics. A risk-adjusted long-term study comparing coronary angioplasty and coronary bypass surgery. Eur Heart J (1998) 1.44

UKPDS 28: a randomized trial of efficacy of early addition of metformin in sulfonylurea-treated type 2 diabetes. U.K. Prospective Diabetes Study Group. Diabetes Care (1998) 1.39

Ischaemic heart-disease in diabetics. A prospective study. Lancet (1972) 1.39

Estimation and prediction in a multi-state model for breast cancer. Biom J (2006) 1.36

Reduced cardiovascular morbidity and mortality associated with metformin use in subjects with Type 2 diabetes. Diabet Med (2005) 1.35

Patterns of persistence with antihypertensive medications in newly diagnosed hypertensive patients in Italy: a retrospective cohort study in primary care. J Hypertens (2005) 1.31

Myocardial infarction in maturity-onset diabetics. A retrospective study. Lancet (1972) 1.17

Secondary failure to treatment with oral antidiabetic agents in non-insulin-dependent diabetes. Diabetes Care (1986) 1.15

Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. VII. Mortality and selected nonfatal events with insulin treatment. JAMA (1978) 1.14

Compliance with sulfonylureas in a health maintenance organization: a pharmacy record-based study. Ann Pharmacother (1999) 1.13

The effects of improved glycemic control on complications in type 2 diabetes. Arch Intern Med (1998) 1.11

Effect of value-added utilities on prescription refill compliance and Medicaid health care expenditures--a study of patients with non-insulin-dependent diabetes mellitus. J Clin Pharm Ther (1993) 1.05

Increased mortality in Type II diabetic patients using sulphonylurea and metformin in combination: a population-based observational study. Diabetologia (2000) 1.02

Measurement of patient compliance. Pharm World Sci (1998) 0.93

Sulphonylurea treatment of NIDDM patients with cardiovascular disease: a mixed blessing? Diabetologia (1996) 0.91

The UGDP controversy: thirty-four years of contentious ambiguity laid to rest. Perspect Biol Med (2004) 0.90

The crux of the UGDP. Spurious results and biologically inappropriate data analysis. Diabetologia (1980) 0.87

Oral antidiabetic treatment in patients with coronary disease: time-related increased mortality on combined glyburide/metformin therapy over a 7.7-year follow-up. Clin Cardiol (2001) 0.86

Refill compliance in type 2 diabetes mellitus: a predictor of switching to insulin therapy? Pharmacoepidemiol Drug Saf (2003) 0.85

Sulfonylureas and the risk of myocardial infarction. Metabolism (2006) 0.82

Mortality in type 2 diabetic subjects prescribed metformin and sulphonylurea drugs in combination: cohort study. Diabetes Metab Res Rev (2004) 0.81

Persistence with oral and transdermal hormone replacement therapy and hospitalisation for cardiovascular outcomes. Maturitas (2007) 0.77

Incidence of new coronary events in older persons with diabetes mellitus and prior myocardial infarction treated with sulfonylureas, insulin, metformin, and diet alone. Am J Cardiol (2001) 0.77

Articles by these authors

Improved glycemic control in poorly controlled patients with type 1 diabetes using real-time continuous glucose monitoring. Diabetes Care (2006) 6.25

A meta-analysis of alcohol consumption and the risk of 15 diseases. Prev Med (2004) 6.24

Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: randomised, double-blind controlled study. Lancet (2007) 3.62

Prevalence, metabolic features, and prognosis of metabolically healthy obese Italian individuals: the Cremona Study. Diabetes Care (2010) 2.42

High titer of autoantibodies to GAD identifies a specific phenotype of adult-onset autoimmune diabetes. Diabetes Care (2007) 2.07

Fatty liver index and mortality: the Cremona study in the 15th year of follow-up. Hepatology (2011) 1.85

Flexible meta-regression functions for modeling aggregate dose-response data, with an application to alcohol and mortality. Am J Epidemiol (2004) 1.82

Genome-wide scans for diabetic nephropathy and albuminuria in multiethnic populations: the family investigation of nephropathy and diabetes (FIND). Diabetes (2007) 1.79

Cancer risk associated with use of metformin and sulfonylurea in type 2 diabetes: a meta-analysis. Oncologist (2012) 1.79

Cardiovascular protection by initial and subsequent combination of antihypertensive drugs in daily life practice. Hypertension (2011) 1.73

Genome-wide scan for estimated glomerular filtration rate in multi-ethnic diabetic populations: the Family Investigation of Nephropathy and Diabetes (FIND). Diabetes (2007) 1.61

Extending indications for islet autotransplantation in pancreatic surgery. Ann Surg (2013) 1.52

Long-term use of statins reduces the risk of hospitalization for dementia. Atherosclerosis (2013) 1.42

Zinc transporter 8 antibodies complement GAD and IA-2 antibodies in the identification and characterization of adult-onset autoimmune diabetes: Non Insulin Requiring Autoimmune Diabetes (NIRAD) 4. Diabetes Care (2009) 1.42

Intensive structured self-monitoring of blood glucose and glycemic control in noninsulin-treated type 2 diabetes: the PRISMA randomized trial. Diabetes Care (2013) 1.42

Cancer risk for patients using thiazolidinediones for type 2 diabetes: a meta-analysis. Oncologist (2013) 1.41

Expansion of Th17 cells and functional defects in T regulatory cells are key features of the pancreatic lymph nodes in patients with type 1 diabetes. Diabetes (2011) 1.39

Heritability of the severity of diabetic retinopathy: the FIND-Eye study. Invest Ophthalmol Vis Sci (2008) 1.29

Better compliance to antihypertensive medications reduces cardiovascular risk. J Hypertens (2011) 1.26

Discontinuation of and changes in drug therapy for hypertension among newly-treated patients: a population-based study in Italy. J Hypertens (2008) 1.23

Effects of carbohydrate counting on glucose control and quality of life over 24 weeks in adult patients with type 1 diabetes on continuous subcutaneous insulin infusion: a randomized, prospective clinical trial (GIOCAR). Diabetes Care (2011) 1.20

Reduction of circulating neutrophils precedes and accompanies type 1 diabetes. Diabetes (2013) 1.17

Epidemic of diabetic and nondiabetic renal disease among the Zuni Indians: the Zuni Kidney Project. J Am Soc Nephrol (2003) 1.14

A population-based, cross-sectional survey of the Zuni Pueblo: a collaborative approach to an epidemic of kidney disease. Am J Kidney Dis (2002) 1.14

Heritability and demographic analyses in the large isolated population of Val Borbera suggest advantages in mapping complex traits genes. PLoS One (2009) 1.11

The Zuni kidney project: a collaborative approach to an epidemic of kidney disease. J Am Soc Nephrol (2003) 1.10

Statins and primary liver cancer: a meta-analysis of observational studies. Eur J Cancer Prev (2013) 1.07

Cytological Ki-67 in pancreatic endocrine tumours: an opportunity for pre-operative grading. Endocr Relat Cancer (2008) 1.07

The protein tyrosine phosphatase nonreceptor 22 (PTPN22) is associated with high GAD antibody titer in latent autoimmune diabetes in adults: Non Insulin Requiring Autoimmune Diabetes (NIRAD) Study 3. Diabetes Care (2007) 1.07

Sexual function and endocrine profile in fertile women with type 1 diabetes. Diabetes Care (2006) 1.05

Glucose variability: An emerging target for the treatment of diabetes mellitus. Diabetes Res Clin Pract (2013) 1.05

Anti-asthma medication prescribing to children in the Lombardy Region of Italy: chronic versus new users. BMC Pulm Med (2011) 1.04

Blood pressure and LDL-cholesterol targets for prevention of recurrent strokes and cognitive decline in the hypertensive patient: design of the European Society of Hypertension-Chinese Hypertension League Stroke in Hypertension Optimal Treatment randomized trial. J Hypertens (2014) 1.03

Heritability of measures of kidney disease among Zuni Indians: the Zuni Kidney Project. Am J Kidney Dis (2010) 1.03

Six months of gluten-free diet do not influence autoantibody titers, but improve insulin secretion in subjects at high risk for type 1 diabetes. J Clin Endocrinol Metab (2003) 1.03

Calcineurin inhibitor-free immunosuppressive regimen in type 1 diabetes patients receiving islet transplantation: single-group phase 1/2 trial. Transplantation (2014) 1.01

Duration of postoperative delirium is an independent predictor of 6-month mortality in older adults after hip fracture. J Am Geriatr Soc (2014) 1.01

Anti-asthmatic drug prescriptions to an Italian paedriatic population. Pediatr Allergy Immunol (2008) 1.00

Reduced discontinuation of antihypertensive treatment by two-drug combination as first step. Evidence from daily life practice. J Hypertens (2010) 0.99

Alloantibody and autoantibody monitoring predicts islet transplantation outcome in human type 1 diabetes. Diabetes (2012) 0.99

Defective differentiation of regulatory FoxP3+ T cells by small-intestinal dendritic cells in patients with type 1 diabetes. Diabetes (2011) 0.99

Autologous pancreatic islet transplantation in human bone marrow. Diabetes (2013) 0.97

Overweight and perception of overweight as predictors of smokeless tobacco use and of cigarette smoking in a cohort of Swedish adolescents. Addiction (2009) 0.97

Estimating dose-response relationship between ethanol and risk of cancer using regression spline models. Int J Cancer (2005) 0.96

Lipid lowering drugs prescription and the risk of peripheral neuropathy: an exploratory case-control study using automated databases. J Epidemiol Community Health (2004) 0.95

Trends in drug prescriptions to diabetic patients from 2000 to 2008 in Italy's Lombardy Region: a large population-based study. Diabetes Res Clin Pract (2011) 0.95

Tissue Doppler, triplane echocardiography, and speckle tracking echocardiography: different ways of measuring longitudinal myocardial velocity and deformation parameters. A comparative clinical study. Echocardiography (2012) 0.94

Determinants of the drug utilization profile in the paediatric population in Italy's Lombardy Region. Br J Clin Pharmacol (2009) 0.93

Oral L-arginine supplementation improves endothelial function and ameliorates insulin sensitivity and inflammation in cardiopathic nondiabetic patients after an aortocoronary bypass. Metabolism (2009) 0.93

Persistence with pharmacological treatment in the specialist mental healthcare of patients with severe mental disorders. Eur J Clin Pharmacol (2012) 0.92

Asymptomatic hyperinsulinemic hypoglycemia after gastric banding. N Engl J Med (2005) 0.92

Alcohol-attributable and alcohol-preventable mortality in Italy. A balance in 1983 and 1996. Eur J Public Health (2002) 0.91

Drug utilization and polypharmacy in an Italian elderly population: the EPIFARM-elderly project. Pharmacoepidemiol Drug Saf (2011) 0.91

Metabolic and immunological features of the failing islet-transplanted patient. Diabetes Care (2007) 0.90

Evidence of tendinitis provoked by fluoroquinolone treatment: a case-control study. Drug Saf (2006) 0.89

Near normalization of metabolic and functional features of the central nervous system in type 1 diabetic patients with end-stage renal disease after kidney-pancreas transplantation. Diabetes Care (2011) 0.89

Trastuzumab-related cardiotoxicity in early breast cancer: a cohort study. Oncologist (2013) 0.89

Risks and benefits of transplantation in the cure of type 1 diabetes: whole pancreas versus islet transplantation. A single center study. Rev Diabet Stud (2011) 0.89

Increased CD36 expression signals monocyte activation among patients with type 2 diabetes. Diabetes Care (2010) 0.89

Short-acting inhaled beta-2-agonists increased the mortality from chronic obstructive pulmonary disease in observational designs. J Clin Epidemiol (2005) 0.89

Identification of tyrosine phosphatase 2(256-760) construct as a new, sensitive marker for the detection of islet autoimmunity in type 2 diabetic patients: the non-insulin requiring autoimmune diabetes (NIRAD) study 2. Diabetes (2008) 0.89

Management of antihypertensive drugs in three European countries. J Hypertens (2009) 0.88

L-arginine enriched biscuits improve endothelial function and glucose metabolism: a pilot study in healthy subjects and a cross-over study in subjects with impaired glucose tolerance and metabolic syndrome. Metabolism (2012) 0.88

Results of a retrospective database analysis of adherence to statin therapy and risk of nonfatal ischemic heart disease in daily clinical practice in Italy. Clin Ther (2010) 0.87

Absence of otoacoustic emissions in insulin-dependent diabetic patients: is there evidence for diabetic cochleopathy? J Diabetes Complications (2002) 0.87

Prospective, randomized trial on intensive SMBG management added value in non-insulin-treated T2DM patients (PRISMA): a study to determine the effect of a structured SMBG intervention. Acta Diabetol (2011) 0.87

Changes in drug prescribing to Italian community-dwelling elderly people: the EPIFARM-Elderly Project 2000-2010. Eur J Clin Pharmacol (2014) 0.87

Aerobic and resistance training effects compared to aerobic training alone in obese type 2 diabetic patients on diet treatment. Diabetes Res Clin Pract (2011) 0.87

Antidepressants utilization among elderly in Lombardy from 2000 to 2007: dispensing trends and appropriateness. Eur J Clin Pharmacol (2011) 0.86

Paediatric drug use with focus on off-label prescriptions in Lombardy and implications for therapeutic approaches. Eur J Pediatr (2013) 0.86

Genome-wide linkage scans for type 2 diabetes mellitus in four ethnically diverse populations-significant evidence for linkage on chromosome 4q in African Americans: the Family Investigation of Nephropathy and Diabetes Research Group. Diabetes Metab Res Rev (2009) 0.86

Better postprandial glucose stability during continuous subcutaneous infusion with insulin aspart compared with insulin lispro in patients with type 1 diabetes. Diabetes Technol Ther (2008) 0.85

Gastroenteric neuroendocrine neoplasms classification: comparison of prognostic models. Cancer (2012) 0.85

Burden of acute myocardial infarction. Int J Cardiol (2011) 0.85

Menstrual cycle-related changes in circulating androgens in healthy women with self-reported normal sexual function. J Sex Med (2008) 0.85

Factors involved in the discontinuation of antihypertensive drug therapy: an analysis from real life data. J Hypertens (2014) 0.85

Blood pressure and low-density lipoprotein-cholesterol lowering for prevention of strokes and cognitive decline: a review of available trial evidence. J Hypertens (2014) 0.85

Changes in trend of antipsychotics prescription in patients treated with cholinesterase inhibitors after warnings from Italian Medicines Agency. Results from the EPIFARM-Elderly Project. Eur Neuropsychopharmacol (2012) 0.85

Elevation of plasma levels of the long pentraxin 3 precedes preeclampsia in pregnant patients with type 1 diabetes. Autoimmunity (2009) 0.84

Autoantibodies to harmonin and villin are diagnostic markers in children with IPEX syndrome. PLoS One (2013) 0.84

Insulin resistance/hyperinsulinemia and cancer mortality: the Cremona study at the 15th year of follow-up. Acta Diabetol (2012) 0.84

Efficacy of computer-aided detection as a second reader for 6-9-mm lesions at CT colonography: multicenter prospective trial. Radiology (2012) 0.84

Rapamycin does not adversely affect intrahepatic islet engraftment in mice and improves early islet engraftment in humans. Islets (2010) 0.84

Continuation of the ESH-CHL-SHOT trial after publication of the SPRINT: rationale for further study on blood pressure targets of antihypertensive treatment after stroke. J Hypertens (2016) 0.83

Time course of hypothalamic-pituitary deficiency in adults receiving cranial radiotherapy for primary extrasellar brain tumors. Radiother Oncol (2011) 0.83

Spirometry testing in a population of Italian children: age and gender differences. Respir Med (2012) 0.83